ARimidex Therapy Compliance Electronic MonitorIng System. A Study to Evaluate the Impact of Educational Material on the Adherence to Treatment With Adjuvant Anastrozole for Postmenopausal Women With Hormone Sensitive Early Breast Cancer.

Trial Profile

ARimidex Therapy Compliance Electronic MonitorIng System. A Study to Evaluate the Impact of Educational Material on the Adherence to Treatment With Adjuvant Anastrozole for Postmenopausal Women With Hormone Sensitive Early Breast Cancer.

Completed
Phase of Trial: Phase III

Latest Information Update: 13 Feb 2012

At a glance

  • Drugs Anastrozole (Primary)
  • Indications Early breast cancer
  • Focus Therapeutic Use
  • Acronyms ARTEMIS
  • Sponsors AstraZeneca
  • Most Recent Events

    • 13 Feb 2012 Actual patient number changed from 107 to 104 as reported by ClinicalTrials.gov.
    • 01 Sep 2011 Actual end date (Mar 2011) added as reported by ClinicalTrials.gov.
    • 01 Sep 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top